Harita Babbar

Harita Babbar has a diverse work experience in the field of quality control, molecular biology, and diagnostics. Harita currently works at BioNTech SE as a Quality Control Analytical Technical Lead, where they lead the technical transfer of molecular and cell-based assays for T cell therapy products. Harita also represents the QC Analytical team as a technical subject matter expert and leads the design and execution of stability studies for these products.

Prior to their current role, Harita worked at Kite Pharma as a Quality Control Analytical Scientist III. Here, they qualified analytical test methods for product release, authored and reviewed SOPs and test methods, and managed sample inventory and labeling.

Harita also has experience at ABL Inc. as an Associate Scientist, where they served as a subject matter expert for molecular biology assay development and optimization. Additionally, they worked as a Laboratory Research Specialist, providing technical support for government contracts and grants, specifically in the area of HIV/SIV viral load analysis.

Before joining ABL Inc., Harita worked as a Scientist at Canon U.S. Life Sciences, where they developed PCR-based genotyping assays for diagnostics of human infectious diseases. Harita performed real-time PCR and high-resolution melting analysis on a daily basis and collaborated with team members to troubleshoot data analysis.

Harita has also gained experience outside the life sciences industry. Harita worked as an Investment Banking Intern at Focus Investment Banking, where they facilitated future business transactions by compiling a list of clinical research organizations and diagnostics companies interested in mergers and acquisitions. Harita utilized financial tools to categorize companies based on services and products provided and collected useful information for communication between buyers and sellers.

Additionally, Harita has internship experience at OncoPlex Diagnostics, where they supported marketing efforts and conducted market research on competitors in the field of cancer diagnostics. Harita was responsible for designing materials to introduce technology to oncologists and expanding the biomarker menu for protein expression analysis.

Early in their career, Harita worked as a Senior Research Fellow at the Division of Seed Science and Technology, IARI, Pusa Campus, and as a Junior Research Fellow at the Division of Plant Pathology, IARI, Pusa Campus. In these roles, they conducted research on pearl millet and wheat diseases, including gene profiling and sequence analysis.

Overall, Harita has demonstrated their expertise in quality control, molecular biology, diagnostics, investment banking, and research. Harita'sexperience spans different industries and showcases their ability to lead technical projects, develop assays, and contribute to the scientific community.

Harita Babbar's education history begins in 2006 when they enrolled at Delhi University and obtained a Bachelor of Science (B.Sc.) degree in Biochemistry in 2009. Continuing their education, they then attended the School of Biotechnology at Gautam Buddha University from 2009 to 2012, where they earned a Master of Technology (M.Tech.) degree in Biotechnology. In 2014, they pursued further studies at Georgetown University School of Medicine, where they completed a Master's Degree in Biotechnology (Bio-Business Track) in 2015.

In addition to their formal education, Harita Babbar has obtained two certifications related to their field of study. In August 2014, they received a certification in Basic Laboratory Safety from Georgetown University Medical Center. Additionally, in the same month and year, they obtained a certification in Research Ethics and Integrity, also from Georgetown University Medical Center.